| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.74M | — |
| Operating expense | — | — |
| Net income | -15.20M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KYNB returned -32.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -14.4% |
| 1 year | -32.7% |
| 5 years | -97.4% |
| 10 years | -98.3% |
| All-time high | $1,577.50 (Jul 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KYNB would be worth today ›No. Kyntra Bio, Inc. has not paid a dividend in the past 12 months.
Kyntra Bio, Inc. stock trades on NASDAQ under the ticker symbol KYNB.
Kyntra Bio, Inc. is part of the Healthcare sector.
Kyntra Bio, Inc. has a market cap of 30.45M USD, based on the latest quote.
Kyntra Bio, Inc. is expected to report earnings around Nov 9, 2026. That date is an estimate and has not been confirmed by the company.
